RELX PLC (RELX)
NYSE: RELX · IEX Real-Time Price · USD
45.40
-0.91 (-1.97%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Company Description

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally.

It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.

The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes.

The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity.

The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions.

The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

RELX PLC
RELX PLC logo
Country United Kingdom
Industry Specialty Business Services
Sector Industrials
Employees 36,500
CEO Erik Engstrom M.Sc Econ, M.Sc Eng., MBA

Contact Details

Address:
1-3 Strand
London Wc2n 5jr, X0 00000
United Kingdom
Phone 011442071665660
Website relx.com

Stock Details

Ticker Symbol RELX
Exchange NYSE
Fiscal Year January - December
Reporting Currency GBP
CIK Code 0000929869
CUSIP Number 759530108
ISIN Number US7595301083
SIC Code 7389

Key Executives

Name Position
Michael Walsh Chief Executive Officer of Legal
Mark Kelsey Chief Executive Officer of Risk
Kumsal Bayazit Besson Chief Executive Officer of Scientific, Technical and Medical
Erik Engstrom M.Sc Econ, M.Sc Eng., MBA Chief Executive Officer and Executive Director
Nicholas Lawrence Luff Chief Financial Officer and Executive Director
Colin Tennant Head of Investor Relations
Henry Adam Udow Chief Legal Officer and Company Secretary
Paul Abrahams Head of Corporate Communications
Rosemary Thomson Chief Human Resources Officer
Jelena Sevo Chief Strategy Officer

Latest SEC Filings

Date Type Title
Jul 1, 2024 6-K Report of foreign issuer
Jun 6, 2024 6-K Report of foreign issuer
Jun 3, 2024 6-K Report of foreign issuer
May 24, 2024 6-K Report of foreign issuer
May 1, 2024 6-K Report of foreign issuer
Apr 26, 2024 6-K Report of foreign issuer
Apr 25, 2024 6-K Report of foreign issuer
Apr 25, 2024 6-K Report of foreign issuer
Apr 25, 2024 6-K Report of foreign issuer
Apr 2, 2024 6-K Report of foreign issuer